D. Darbar et al., PREDICTION OF LATE CARDIAC EVENTS BY DIPYRIDAMOLE-THALLIUM SCINTIGRAPHY IN PATIENTS WITH INTERMITTENT CLAUDICATION AND OCCULT CORONARY-ARTERY DISEASE, The American journal of cardiology, 78(7), 1996, pp. 736-740
Concomitant coronary artery disease often occurs in patients with peri
pheral vascular disease, but it may be asymptomatic. Despite being asy
mptomatic, cardiovascular events are the main source of morbidity and
mortality in this group of patients, Dipyridamole thallium scintigraph
y has been shown to be of prognostic value in patients with peripheral
vascular disease and symptomatic coronary artery disease, but its eff
ect on the long-term outcome in the asymptomatic group of patients is
less defined. Eighty-four consecutive patients with peripheral vascula
r disease and pro symptoms of coronary artery disease were therefore e
valuated by clinical assessment, dipyridamole thallium imaging, radion
uclide ventriculography, and cardiac catheterization and followed for
a mean of 66 months, Abnormal perfusion patterns were found on thalliu
m scintigraphy in 48 patients (57%); fixed, mixed, and reversible defe
cts were present in 14 (17%), 11 (13%), and 23 (27%) patients, respect
ively. Significant coronary artery disease was present in 52 patients
(69%) and mean left ventricular ejection fraction was 44%. During the
follow-up period, 23 patients had a cardiac event (nonfatal myocardial
infarction or cardiac death). Univariate analysis of 15 clinical, sci
ntigraphic, radionuclide, and angiographic variables revealed that age
, angiographic extent of coronary artery disease, and an abnormal thal
lium scan were significant predictors of subsequent cardiac events. Mu
ltivariate stepwise logistic regression analyses selected fixed and mi
xed thallium defects and diffuse coronary artery disease as the only s
ignificant independent predictors of outcome. Thus, the present study
shows the value of dipyridamole thallium scintigraphy as a valuable pr
ognostic indicator for long-term event-free survival in a cohort of pa
tients with peripheral vascular disease and no history or symptoms of
coronary artery disease.